Insights on interferon-independent induction of interferon-stimulated genes shaping the lung's response in early SARS-CoV-2 infection
- PMID: 38125412
- PMCID: PMC10731229
- DOI: 10.1016/j.heliyon.2023.e22997
Insights on interferon-independent induction of interferon-stimulated genes shaping the lung's response in early SARS-CoV-2 infection
Abstract
While mRNA vaccine efficacy against the 2019 coronavirus disease (COVID-19) outbreak remains high, research on antiviral innate immune responses in the early stages of infection is essential to develop strategies to prevent the dissemination of SARS-CoV-2. In this study, we investigated the induction of both interferon (IFN)-stimulated genes (ISGs) and IFN-independently upregulated ISGs following SARS-CoV-2 infection in Syrian golden hamsters. The viral titers were highest at 3 days post-infection (dpi). Over time, the viral titer gradually decreased while ISGs such as Mx1, Ifit2, Ifit3, Ifi44, and Rsad2 were markedly induced in the lung. The transcription of ISGs significantly increased from 2 dpi, and SARS-CoV-2-induced ISGs were maintained in the hamster lung until 7 dpi. The transcription of Ifnb and Ifng was minimally elevated, while Ifnl2/3 was significantly induced in the lung at 5 days after SARS-CoV-2 infection. RNA sequencing results also showed that at 3 dpi, SARS-CoV-2 initiated the activation of ISGs, with lesser increases of Ifnl2 and Ifnl3 transcription. In addition, Ddx58 and cGAS, which encode factors for virus sensing, Stat1, Stat2, and IFN regulatory factor 7 and 9 mRNA levels were also induced at the initial stage of infection. Our data demonstrate that ISGs might be upregulated in the lung in response to SARS-CoV-2 during the early stages of infection, and the rapid induction of ISGs was not associated with the activation of IFNs. Elucidation of IFN-independent induction of ISGs could further our understanding of alternative defense mechanisms employed by the lungs against SARS-CoV-2 and provide more effective antiviral strategies for patients with severe COVID-19.
Keywords: Innate immune responses; Interferon-independent pathway; Interferon-stimulated genes; SARS-CoV-2.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20. mBio. 2020. PMID: 32913009 Free PMC article.
-
Intranasal inoculation of IFN-λ resolves SARS-CoV-2 lung infection via the rapid reduction of viral burden and improvement of tissue damage.Front Immunol. 2022 Nov 29;13:1009424. doi: 10.3389/fimmu.2022.1009424. eCollection 2022. Front Immunol. 2022. PMID: 36524125 Free PMC article.
-
Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.Viruses. 2022 Mar 23;14(4):667. doi: 10.3390/v14040667. Viruses. 2022. PMID: 35458397 Free PMC article.
-
Mechanisms of Antiviral Immune Evasion of SARS-CoV-2.J Mol Biol. 2022 Mar 30;434(6):167265. doi: 10.1016/j.jmb.2021.167265. Epub 2021 Sep 22. J Mol Biol. 2022. PMID: 34562466 Free PMC article. Review.
-
The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses.Cytokine Growth Factor Rev. 2016 Jun;29:71-81. doi: 10.1016/j.cytogfr.2016.02.010. Epub 2016 Mar 18. Cytokine Growth Factor Rev. 2016. PMID: 27053489 Review.
Cited by
-
Integrated multi-sample transcriptomic analysis of COVID-19 patients against controls using a bioinformatics pipeline.Sci Rep. 2025 Jun 4;15(1):19644. doi: 10.1038/s41598-025-03640-1. Sci Rep. 2025. PMID: 40467710 Free PMC article.
-
Expression of interferon-stimulated genes, but not polymorphisms in the interferon α/β receptor 2 gene, is associated with coronavirus disease 2019 mortality.Heliyon. 2024 Oct 5;10(19):e39002. doi: 10.1016/j.heliyon.2024.e39002. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39435115 Free PMC article.
-
CD8+ T Cells Mediate Lethal Lung Pathology in the Absence of PD-L1 and Type I Interferon Signalling following LCMV Infection.Viruses. 2024 Mar 1;16(3):390. doi: 10.3390/v16030390. Viruses. 2024. PMID: 38543756 Free PMC article.
References
-
- Norddahl G.L., Melsted P., Gunnarsdottir K., Halldorsson G.H., Olafsdottir T.A., Gylfason A., Kristjansson M., Magnusson O.T., Sulem P., Gudbjartsson D.F., Thorsteinsdottir U., Jonsdottir I., Stefansson K. Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland. Nat. Commun. 2022;13:5701. - PMC - PubMed
-
- Lederer K., Castaño D., Gómez Atria D., Oguin T.H., 3rd, Wang S., Manzoni T.B., Muramatsu H., Hogan M.J., Amanat F., Cherubin P., Lundgreen K.A., Tam Y.K., Fan S.H.Y., Eisenlohr L.C., Maillard I., Weissman D., Bates P., Krammer F., Sempowski G.D., Pardi N., Locci M. SARS-CoV-2 mRNA vaccines Foster potent antigen-specific germinal center responses associated with neutralizing antibody generation. Immunity. 2020;53:1281–1295. - PMC - PubMed
-
- Hoagland D.A., Møller R., Uhl S.A., Oishi K., Frere J., Golynker I., Horiuchi S., Panis M., Blanco-Melo D., Sachs D., Arkun K., Lim J.K., tenOever B.R. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity. 2021;54:557–570. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous